The emerging practice of combining kratom, a available botanical, with opioid medication – often referred to as "Kratom Lean" – presents a intricate legal ambiguity. For now, the federally regulated status of kratom is in flux, varying considerably by state among localities, while codeine’s contr

Research compounds, often known as "novel psychoactive materials," present a complex challenge due to their evolving nature. These products are typically created for scientific exploration, but are frequently encountered in the street drug scene. The lack of extensive research on their potential

The concerning combination is appearing among individuals: the concurrent consumption of legal lean syrup – often containing this cough suppressant – and kratom, a tropical plant. This hazardous pairing presents grave physical threats. Both substances independently carry important hazard, but